Amgen (AMGN) Tops Q4 EPS by 18c
Tweet
Share
E-mail_58cbc46cd3c33.jpg)
Get Alerts AMGN Hot Sheet
Price: $344.72 +2.11%
EPS Growth %: -7.1%
Financial Fact:
Other revenues: 295M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -7.1%
Financial Fact:
Other revenues: 295M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q4 EPS of $3.64, $0.18 better than the analyst estimate of $3.46. Revenue for the quarter came in at $6.2 billion versus the consensus estimate of $6.06 billion.
GUIDANCE:
Amgen sees FY2020 EPS of $14.85-$15.60, versus the consensus of $16.14. Amgen sees FY2020 revenue of $25-25.6 billion, versus the consensus of $25.5 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Amgen (AMGN) PT Raised to $303 at Mizuho
- C.H. Robinson acquires DeSpir Logistics for $75 million
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
